Purchase Order 75N91024P00165
Award Date 1/5/24
Potential Completion Date 1/4/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hercules, CA 94547, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,340 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for maintenance services. As the prime contractor, Bio-Rad will perform the maintenance under a firm fixed price contract running from September 2029 through September 2024 at its headquarters location in Hercules, California. The National Cancer Institute supports a wide range of cancer research efforts and...
- Bio-Rad Laboratories, Inc. Life Science Group Division has been awarded a $19,536 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide maintenance services for equipment located in Hercules, California under a maintenance agreement expiring March 31, 2024. This award is not designated as a set-aside. Bio-Rad Laboratories holds a five-year, one billion dollar blanket purchase agreement with the Department...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,671 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a service agreement for digital PCR instruments. As the prime contractor, Bio-Rad will provide services and support for digital PCR instruments located at the National Cancer Institute in Rockville, Maryland over a one year period from November 2023 through November 2024. The contract is a firm fixed...
- This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The $18,625.40 contract is for a maintenance agreement, with a period of performance ending on April 5, 2025. Bio-Rad Laboratories, Inc. is an experienced federal contractor that has been awarded numerous contracts and...
- This federal contract award is for a MAINTENANCE AGREEMENT between the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), and Bio-Rad Laboratories, Inc. The contract has a ceiling value of $10,783.00 and a completion date of December 31, 2025. It was awarded on January 1, 2025 as a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and is a global...
- Bio-Rad Laboratories, Inc. was awarded a $46,476.12 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to provide maintenance service for the QX200 system. Performance will take place in Hercules, California with an estimated completion date of April 14, 2025. This purchase order was issued off the five-year, $1 billion blanket purchase agreement Bio-Rad maintains with the Department of Health...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $25,000 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a CHEMIDOC imaging system. The firm fixed price contract has a period of performance from December 31, 2023 through December 31, 2023 for delivery of the requested product to Bio-Rad's facility in Hercules, California. No set aside designation or subcontractors were identified. The CHEMIDOC...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a firm fixed-price purchase order valued at $3,771.36 to Bio-Rad Laboratories, Inc. for maintenance of real-time polymerase chain reaction systems. Bio-Rad Laboratories, Inc., through its Life Science Group Division, will provide maintenance and support services for CFX 96W real-time PCR detection systems located at its facility in Hercules, California...
- The National Cancer Institute awarded a $24,995 firm fixed-price Blanket Purchase Agreement (BPA) call to Bio-Rad Laboratories, Inc.'s Life Science Group Division on September 14, 2016, for laboratory equipment and supplies. The contract was completed by October 7, 2016, with performance at the NCI facility in Bethesda, Maryland. This award was not designated as a small business set-aside, consistent with Bio-Rad's positioning as an established large federal contractor. The call was placed...
- This federal contract award, with ID 75N91020P00251, is for a maintenance agreement between the National Cancer Institute and Bio-Rad Laboratories, Inc. The $20,112.02 firm fixed-price contract does not have a set-aside designation. The contract was awarded on February 18, 2020 with an ultimate completion date of April 5, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics. The company has established...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $23,340 purchase order to Bio-Rad Laboratories, Inc.'s Diagnostics Division for maintenance services. As the prime contractor, Bio-Rad Laboratories will perform the maintenance work itself at its facility in Hercules, California under a firm fixed price contract that runs from January 2024 through January 2025. No subcontractors or set-aside designations were identified. The award provides maintenance for equipment that likely supports the National Cancer Institute's research efforts to prevent and cure cancer through scientific discovery.
Generated 12/28/23, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 12/27/23 |